Teosyal Redensity II Under-Eye Filler
Teosyal Redensity II is a premium hyaluronic acid dermal filler specifically formulated for the delicate under-eye area. Developed by Teoxane, Redensity II is designed to address the appearance of dark circles, tear troughs, under-eye hollows and signs of fatigue, while supporting a smoother, more refreshed and naturally rejuvenated appearance.
Unlike conventional dermal fillers that focus primarily on adding volume, Redensity II combines cross-linked hyaluronic acid with a carefully selected dermal-revitalising complex containing amino acids, antioxidants, vitamins and minerals. This formulation is designed to provide both subtle volumisation and improved skin quality in the delicate periorbital region.
Key Benefits of Teosyal Redensity II
- Specially formulated for the delicate under-eye and periorbital area
- Helps correct the appearance of tear troughs and under-eye hollows
- Designed to reduce the appearance of tired-looking eyes
- Helps improve the appearance of dark circles associated with shadowing and volume loss
- Contains 15 mg/mL cross-linked hyaluronic acid
- Includes 0.3% lidocaine to enhance patient comfort
- Formulated with a comprehensive dermal-revitalising complex
- Provides subtle, natural-looking correction
- Helps improve skin hydration and smoothness
- Designed to integrate naturally into the delicate under-eye area
- Suitable for professional aesthetic treatment protocols
Redensity II Ingredients
Redensity II contains cross-linked hyaluronic acid alongside a dermal-revitalising complex containing a combination of:
- Hyaluronic acid
- Amino acids
- Antioxidants
- Vitamins
- Minerals
- Coenzymes
This combination is designed to provide hydration and support skin quality alongside the product’s volumising properties.
Recommended Treatment Areas
Redensity II is primarily designed for treatment of the periorbital region, including:
- Tear troughs
- Under-eye hollows
- Infraorbital area
- Dark circles caused by shadowing and volume depletion
- Fine lines around the eyes
- Signs of tiredness associated with under-eye volume loss
Because the periorbital area is anatomically delicate and highly vascularised, treatment should only be performed by an appropriately trained and qualified medical professional with suitable experience in under-eye injectable treatments.
Product Specifications
| Specification | Details |
|---|---|
| Product | Teosyal Redensity II |
| Product Type | Hyaluronic Acid Dermal Filler |
| Manufacturer | Teoxane Laboratories |
| Main Ingredient | Cross-linked Hyaluronic Acid |
| HA Concentration | 15 mg/mL |
| Lidocaine | 0.3% |
| Syringe Volume | 1 mL |
| Pack Size | 2 × 1 mL pre-filled syringes |
| Primary Treatment Area | Infraorbital / Periorbital Area |
| Treatment Indication | Under-eye hollows and tear trough correction |
| Technology | RHA-based Teoxane technology |
| Needles | Refer to current product packaging |
| Regulatory Status | CE Marked |
| Storage | Refer to manufacturer’s current Instructions for Use |
Redensity II for Tear Troughs
Tear trough correction requires a filler specifically suited to the anatomy and movement of the under-eye area. Redensity II was developed specifically for this application, offering a softer, more specialised approach to infraorbital correction.
By addressing volume deficiency within the tear trough region, treatment can help reduce the appearance of shadows beneath the eyes. This may result in a brighter and more rested appearance while maintaining natural facial movement.
For professional use only. Redensity II should only be administered by appropriately qualified and trained medical professionals in accordance with the manufacturer’s current Instructions for Use, applicable regulations and professional standards.
Product specifications, indications, packaging and regulatory information can vary by market. Always verify the current manufacturer’s documentation and product packaging before treatment.


